Coastwise Capital Group LLC Increases Stake in Colgate-Palmolive (NYSE:CL)

Coastwise Capital Group LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 5.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,936 shares of the company’s stock after purchasing an additional 221 shares during the quarter. Coastwise Capital Group LLC’s holdings in Colgate-Palmolive were worth $409,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Ascent Group LLC grew its position in shares of Colgate-Palmolive by 3.1% in the third quarter. Ascent Group LLC now owns 14,457 shares of the company’s stock valued at $1,501,000 after purchasing an additional 435 shares in the last quarter. Benjamin Edwards Inc. increased its position in shares of Colgate-Palmolive by 10,946.5% during the third quarter. Benjamin Edwards Inc. now owns 106,157 shares of the company’s stock valued at $11,020,000 after buying an additional 105,196 shares during the period. Kestra Investment Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter worth about $1,079,000. FSA Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $207,000. Finally, B&L Asset Management LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $595,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.1 %

Shares of Colgate-Palmolive stock opened at $96.63 on Monday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52-week low of $75.50 and a 52-week high of $109.30. The company’s 50 day moving average price is $97.38 and its 200-day moving average price is $98.64. The stock has a market capitalization of $78.95 billion, a price-to-earnings ratio of 27.69, a P/E/G ratio of 3.45 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.34% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on CL shares. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. TD Cowen lowered their price target on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price objective for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Finally, UBS Group lifted their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.